MBIA Inc.
MBI Real Time Price USDRecent trades of MBI by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by MBI's directors and management
* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.
- 1M
- 3M
- 6M
- YTD
- 1Y
- 2Y
- 5Y
- MAX
About
Key Metrics
Return (1d)
Return (30d)
Return (1Y)
CAGR (Total)
Max Drawdown
Beta
Alpha
Sharpe Ratio
Win Rate
Average Win
Average Loss
Annual Volatility
Annual Std Dev
Information Ratio
Treynor Ratio
Total Trades
Metrics Definitions
-
Alpha
Measures a portfolio's risk-adjusted performance against that of its benchmark
Learn More -
Annual Standard Deviation
Measures how much the portfolio's total return varies from its mean or average.
Learn More -
Annual Volatility
A statistical measure of the dispersion of returns for the portfolio.
Learn More -
Average Win
The average return (%) for trades that resulted in a positive return.
-
Average Loss
The average return (%) for trades that resulted in a negative return.
-
Beta
A measure of the volatility of the portfolio compared to the market as a whole.
Learn More -
CAGR
CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.
Learn More -
Information Ratio
A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.
Learn More -
Max Drawdown
the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.
Learn More -
Sharpe Ratio
The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.
Learn More -
Total Trades
The total number of trades made by this strategy.
-
Treynor Ratio
Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.
Learn More -
Win Rate
The percentage of total trades that resulted in a positive return.
Be the first to see our newest insights and key updates across all datasets.
Government lobbying spending instances
-
$10,000 May 31, 2022 Issue: Aviation/Airlines/Airports
-
$40,000 May 12, 2022 Issue: Science/Technology Natural Resources Budget/Appropriations
-
$20,000 May 11, 2022 Issue: Economics/Economic Development
-
$20,000 May 11, 2022 Issue: Economics/Economic Development
-
$7,000 May 09, 2022 Issue: Banking
-
$30,000 Apr 21, 2022 Issue: Education
-
$40,000 Apr 20, 2022 Issue: Education Immigration Health Issues Budget/Appropriations
-
$30,000 Apr 20, 2022 Issue: Taxation/Internal Revenue Code Pharmacy Medical/Disease Research/Clinical Labs Health Issues
-
$20,000 Apr 20, 2022 Issue: None
-
$15,000 Apr 20, 2022 Issue: Budget/Appropriations
-
$10,000 Apr 20, 2022 Issue: Disaster Planning/Emergencies
-
$20,000 Apr 20, 2022 Issue: Environment/Superfund
-
$50,000 Apr 20, 2022 Issue: District of Columbia
-
$30,000 Apr 19, 2022 Issue: Energy/Nuclear
-
$20,000 Apr 19, 2022 Issue: Medical/Disease Research/Clinical Labs
-
$30,000 Apr 19, 2022 Issue: Foreign Relations Natural Resources Utilities Energy/Nuclear
-
$20,000 Apr 19, 2022 Issue: Urban Development/Municipalities
-
$5,000 Apr 18, 2022 Issue: Labor Issues/Antitrust/Workplace Roads/Highway
-
$80,000 Apr 18, 2022 Issue: Medicare/Medicaid Health Issues
-
$400,000 Apr 14, 2022 Issue: Medicare/Medicaid Health Issues
-
$30,000 Apr 12, 2022 Issue: Economics/Economic Development Defense Budget/Appropriations
-
$10,000 Feb 23, 2022 Issue: Agriculture Transportation Natural Resources Budget/Appropriations
-
$20,000 Jan 20, 2022 Issue: None
-
$30,000 Jan 20, 2022 Issue: Medical/Disease Research/Clinical Labs Pharmacy Health Issues
-
$40,000 Jan 20, 2022 Issue: Natural Resources Science/Technology Budget/Appropriations
-
$20,000 Jan 20, 2022 Issue: Aviation/Airlines/Airports
-
$30,000 Jan 20, 2022 Issue: Utilities Natural Resources Energy/Nuclear Foreign Relations
-
$60,000 Jan 20, 2022 Issue: Disaster Planning/Emergencies
-
$10,000 Jan 20, 2022 Issue: Trade (domestic/foreign)
-
$50,000 Jan 20, 2022 Issue: District of Columbia
-
$20,000 Jan 20, 2022 Issue: Environment/Superfund
-
$50,000 Jan 20, 2022 Issue: None
-
$20,000 Jan 19, 2022 Issue: Medical/Disease Research/Clinical Labs
-
$20,000 Jan 19, 2022 Issue: Energy/Nuclear
-
$15,000 Jan 19, 2022 Issue: Budget/Appropriations
-
$30,000 Jan 18, 2022 Issue: Defense Economics/Economic Development Budget/Appropriations
-
$30,000 Jan 17, 2022 Issue: Education
-
$20,000 Jan 16, 2022 Issue: Urban Development/Municipalities
-
$10,000 Jan 15, 2022 Issue: Taxation/Internal Revenue Code
-
$420,000 Jan 14, 2022 Issue: None
-
$5,000 Jan 11, 2022 Issue: Labor Issues/Antitrust/Workplace Roads/Highway
-
$80,000 Jan 07, 2022 Issue: None
-
$7,000 Nov 23, 2021 Issue: None
-
$20,000 Nov 19, 2021 Issue: Aviation/Airlines/Airports
-
$10,000 Nov 05, 2021 Issue: Natural Resources Budget/Appropriations Agriculture Transportation
-
$30,000 Oct 22, 2021 Issue: Education
-
$20,000 Oct 21, 2021 Issue: Economics/Economic Development Education
-
$30,000 Oct 20, 2021 Issue: Health Issues Medical/Disease Research/Clinical Labs Pharmacy
-
$40,000 Oct 20, 2021 Issue: None
-
$20,000 Oct 20, 2021 Issue: Environment/Superfund
-
$50,000 Oct 20, 2021 Issue: Disaster Planning/Emergencies
-
$20,000 Oct 20, 2021 Issue: None
-
$20,000 Oct 20, 2021 Issue: Urban Development/Municipalities
-
$30,000 Oct 20, 2021 Issue: Natural Resources Utilities Energy/Nuclear Foreign Relations
-
$10,000 Oct 20, 2021 Issue: Trade (domestic/foreign)
-
$50,000 Oct 20, 2021 Issue: District of Columbia
-
$20,000 Oct 20, 2021 Issue: Energy/Nuclear
-
$20,000 Oct 19, 2021 Issue: Medical/Disease Research/Clinical Labs
-
$30,000 Oct 19, 2021 Issue: Budget/Appropriations Economics/Economic Development Defense
-
$30,000 Oct 18, 2021 Issue: Budget/Appropriations Natural Resources Science/Technology
-
$10,000 Oct 16, 2021 Issue: Taxation/Internal Revenue Code
-
$390,000 Oct 12, 2021 Issue: None
-
$80,000 Oct 12, 2021 Issue: None
-
$5,000 Oct 01, 2021 Issue: Labor Issues/Antitrust/Workplace Roads/Highway
-
$30,000 Aug 26, 2021 Issue: Budget/Appropriations Science/Technology Natural Resources
-
$30,000 Aug 26, 2021 Issue: Science/Technology Budget/Appropriations Natural Resources
-
$10,000 Aug 06, 2021 Issue: Natural Resources Budget/Appropriations Agriculture Transportation
-
$20,000 Aug 05, 2021 Issue: Aviation/Airlines/Airports
-
$7,000 Aug 05, 2021 Issue: Banking
-
$10,000 Jul 22, 2021 Issue: Education
-
$10,000 Jul 20, 2021 Issue: Trade (domestic/foreign)
-
$30,000 Jul 20, 2021 Issue: Health Issues Pharmacy Medical/Disease Research/Clinical Labs
-
$40,000 Jul 20, 2021 Issue: None
-
$20,000 Jul 20, 2021 Issue: Economics/Economic Development Education
-
$20,000 Jul 20, 2021 Issue: Education Economics/Economic Development
-
$20,000 Jul 20, 2021 Issue: Environment/Superfund
-
$50,000 Jul 20, 2021 Issue: District of Columbia
-
$30,000 Jul 19, 2021 Issue: Utilities Natural Resources Foreign Relations Energy/Nuclear
-
$5,000 Jul 19, 2021 Issue: Labor Issues/Antitrust/Workplace Roads/Highway
-
$20,000 Jul 18, 2021 Issue: Energy/Nuclear
-
$20,000 Jul 17, 2021 Issue: Medical/Disease Research/Clinical Labs
-
$20,000 Jul 17, 2021 Issue: Urban Development/Municipalities
-
$20,000 Jul 16, 2021 Issue: None
-
$410,000 Jul 15, 2021 Issue: None
-
$80,000 Jul 13, 2021 Issue: None
-
$30,000 Jul 09, 2021 Issue: Budget/Appropriations Economics/Economic Development Defense
-
$20,000 Jun 25, 2021 Issue: Aviation/Airlines/Airports
-
$7,000 May 26, 2021 Issue: Banking
-
$20,000 Apr 21, 2021 Issue: None
-
$30,000 Apr 20, 2021 Issue: Medical/Disease Research/Clinical Labs Pharmacy Health Issues
-
$10,000 Apr 20, 2021 Issue: Trade (domestic/foreign)
-
$30,000 Apr 20, 2021 Issue: None
-
$50,000 Apr 20, 2021 Issue: District of Columbia Budget/Appropriations
-
$30,000 Apr 19, 2021 Issue: Energy/Nuclear Utilities Natural Resources Foreign Relations
-
$10,000 Apr 19, 2021 Issue: Medical/Disease Research/Clinical Labs
-
$20,000 Apr 19, 2021 Issue: Budget/Appropriations
-
$20,000 Apr 19, 2021 Issue: Energy/Nuclear
-
$20,000 Apr 18, 2021 Issue: Urban Development/Municipalities
-
$80,000 Apr 14, 2021 Issue: None
-
$30,000 Apr 13, 2021 Issue: Economics/Economic Development Defense Budget/Appropriations
Estimated quarterly lobbying spending
MBI Revenue by Segment or Geography
New patents grants
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Recent insights relating to MBI
Recent picks made for MBI stock on CNBC
ETFs with the largest estimated holdings in MBI
- ... Highest Price Target
- ... Median Price Target
- ... Lowest Price Target
|
Analyst
|
Firm
|
Current
|
Previous
|
Date
|
|---|
- Is $MBI stock a Buy, Sell, or Hold?
- What is the price target for $MBI stock?
* Analyst consensus is not financial advice. Please see our data disclaimers .
|
Shareholder
|
Shares Held
|
|---|
- Who owns $MBI stock?
- Who owns the most shares of $MBI stock?
- What funds own $MBI stock?
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view MBI Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.